The Carcinoembryonic Antigen Testing Market size is expected to grow at an annual average CAGR of 6% during 2022-2028. The cancer embryonic antigen (CEA) test is used to diagnose and treat colon and rectal cancer. CEA is a glycoprotein present in embryonic endoderm epithelial cells. The best use of CEA is as a tumor marker, […]
